London UK – 01 March 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the closure of an agreement with Aspen (JSE: APN) aligned with GSK’s strategy of simplification through focusing on core therapeutic areas. GSK has divested its anaesthesia portfolio to Aspen (excluding the US and Canada which had been previously divested) for £180m plus […]
INDIANAPOLIS, March 1, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. (NASD:CLCD). The tender offer for all outstanding shares of common stock of CoLucid, at a price of $46.50 per share, expired as scheduled on Tuesday, February 28, 2017. As of the expiration […]
Sensor EnabledTM tool complements the EnSite PrecisionTM cardiac mapping system and expands Abbott’s comprehensive advanced cardiac mapping and ablation portfolio ABBOTT PARK, Ill., March 1, 2017 — Abbott today announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility™ Ablation Catheter, Sensor Enabled™ designed to improve the versatility and precision during cardiac ablation procedures […]
INDIANAPOLIS, Feb. 28, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will highlight new Phase 3 data evaluating Taltz® (ixekizumab) for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis at the 75th annual meeting of the American Academy of Dermatology (AAD), which will take place March 3-7, 2017, in Orlando, Fla. Lilly will […]
Findings Reinforce the Need for Greater Discussions Between Health Care Professionals and Patients to Help Them Understand Their Increased Risk For Pneumococcal Pneumonia/Pneumococcal Disease, Flu and Hepatitis B KENILWORTH, N.J. February 28, 2017 –(BUSINESS WIRE)–Many adults with diabetes are unaware of their increased risk for certain serious illnesses, including pneumococcal pneumonia/pneumococcal disease, flu and hepatitis […]
Scientists identify biomarkers in mucous that verify viral infection from cold or flu DURHAM, N.C. February 22, 2017 – It may seem obvious, but the key to confirming whether someone is suffering from a cold or flu virus might lie at the misery’s source — the inflamed passages of the nose and throat. Duke Health […]
Shutting down this source at the root cause could improve cancer survival DURHAM, N.C. February 21, 2017 – Advanced prostate cancer and high blood cholesterol have long been known to be connected, but it has been a chicken-or-egg problem. Now a team led by researchers at the Duke Cancer Institute have identified a cellular process […]
Overall survival and development of infants born at 23, 24 weeks improving, study finds DURHAM, N.C. February 15, 2017 – Babies born at just 22 to 24 weeks of pregnancy continue to have sobering outlooks — only about 1 in 3 survive. But according to a new study led by Duke Health and appearing Feb. […]
DURHAM, N.C. February 14, 2017 – Driven by a shared commitment to enhance and broadly extend the scope, quality and value of heart care services for patients throughout Wake County, Duke Health and WakeMed Health & Hospitals have agreed to combine their nationally and regionally renowned heart programs in a single heart service. This collaboration […]
Collaboration will deliver greater value, more coordinated health care to patients in Wake County RALEIGH, N.C. (February 14, 2017) — WakeMed Health & Hospitals and Duke Health have signed a joint operating agreement to work together to deliver highly-coordinated cardiovascular care, a broader scope of services and greater value and affordability to Wake County’s growing […]